D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide.
Saved in:
| Title: | D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide. |
|---|---|
| Authors: | McKean WB; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Yang J; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA., Boucher K; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Department of Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Shrieve DC; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Suneja G; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Salzman K; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiology, University of Utah School of Medicine, Salt Lake City, Utah, USA., Jensen R; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA., Colman H; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA., Cohen AL; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Division of Oncology, Inova Schar Cancer Institute, Fairfax, Virginia, USA. |
| Source: | Neuro-oncology advances [Neurooncol Adv] 2024 Apr 23; Vol. 6 (1), pp. vdae063. Date of Electronic Publication: 2024 Apr 23 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38800698 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22McKean+WB%22">McKean WB</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Yang+J%22">Yang J</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Boucher+K%22">Boucher K</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Department of Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Shrieve+DC%22">Shrieve DC</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Suneja+G%22">Suneja G</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Salzman+K%22">Salzman K</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Radiology, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Jensen+R%22">Jensen R</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Colman+H%22">Colman H</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Cohen+AL%22">Cohen AL</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Medical Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Division of Oncology, Inova Schar Cancer Institute, Fairfax, Virginia, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101755003%22">Neuro-oncology advances</searchLink> [Neurooncol Adv] 2024 Apr 23; Vol. 6 (1), pp. vdae063. <i>Date of Electronic Publication: </i>2024 Apr 23 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101755003 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-2498 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226322498%22">26322498 </searchLink><i>NLM ISO Abbreviation: </i>Neurooncol Adv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38800698 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/noajnl/vdae063 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: vdae063 Titles: – TitleFull: D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: McKean WB – PersonEntity: Name: NameFull: Yang J – PersonEntity: Name: NameFull: Boucher K – PersonEntity: Name: NameFull: Shrieve DC – PersonEntity: Name: NameFull: Suneja G – PersonEntity: Name: NameFull: Salzman K – PersonEntity: Name: NameFull: Jensen R – PersonEntity: Name: NameFull: Colman H – PersonEntity: Name: NameFull: Cohen AL IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 04 Text: 2024 Apr 23 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2632-2498 Numbering: – Type: volume Value: 6 – Type: issue Value: 1 Titles: – TitleFull: Neuro-oncology advances Type: main |
| ResultId | 1 |